BRPI0412933A - derivados de nicotinamida úteis como inibidores de pde4 - Google Patents

derivados de nicotinamida úteis como inibidores de pde4

Info

Publication number
BRPI0412933A
BRPI0412933A BRPI0412933-4A BRPI0412933A BRPI0412933A BR PI0412933 A BRPI0412933 A BR PI0412933A BR PI0412933 A BRPI0412933 A BR PI0412933A BR PI0412933 A BRPI0412933 A BR PI0412933A
Authority
BR
Brazil
Prior art keywords
derivatives
pde4 inhibitors
derivatives useful
nicotinamide derivatives
nicotinamide
Prior art date
Application number
BRPI0412933-4A
Other languages
English (en)
Inventor
John Paul Mathias
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of BRPI0412933A publication Critical patent/BRPI0412933A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

"DERIVADOS DE NICOTINAMIDA úTEIS COMO INIBIDORES DE PDE4". Esta invenção relaciona-se com derivados de nicotinamida de fórmula geral (I): em que R¬ 1¬, R¬ 2¬ e R¬ 3¬ têm os significados aqui definidos, e com processos para a preparação de tais derivados, intermediários usados na preparação de tais derivados, composições contendo tais derivados e os usos de tais derivados.
BRPI0412933-4A 2003-07-25 2004-07-13 derivados de nicotinamida úteis como inibidores de pde4 BRPI0412933A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0317509.8A GB0317509D0 (en) 2003-07-25 2003-07-25 Nicotinamide derivatives useful as PDE4 inhibitors
PCT/IB2004/002365 WO2005010001A1 (en) 2003-07-25 2004-07-13 Nicotinamide derivatives useful as pdea4 inhibitors

Publications (1)

Publication Number Publication Date
BRPI0412933A true BRPI0412933A (pt) 2006-09-26

Family

ID=27772736

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0412933-4A BRPI0412933A (pt) 2003-07-25 2004-07-13 derivados de nicotinamida úteis como inibidores de pde4

Country Status (7)

Country Link
EP (1) EP1651647A1 (pt)
JP (1) JP2006528623A (pt)
BR (1) BRPI0412933A (pt)
CA (1) CA2533681A1 (pt)
GB (1) GB0317509D0 (pt)
MX (1) MXPA06000988A (pt)
WO (1) WO2005010001A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20060272A1 (es) 2004-05-24 2006-05-22 Glaxo Group Ltd (2r,3r,4s,5r,2'r,3'r,4's,5's)-2,2'-{trans-1,4-ciclohexanodiilbis-[imino(2-{[2-(1-metil-1h-imidazol-4-il)etil]amino}-9h-purin-6,9-diil)]}bis[5-(2-etil-2h-tetrazol-5-il)tetrahidro-3,4-furanodiol] como agonista a2a
PL1888033T3 (pl) * 2005-06-09 2014-09-30 Meda Ab Sposób i kompozycja do leczenia chorób zapalnych
GB0514809D0 (en) 2005-07-19 2005-08-24 Glaxo Group Ltd Compounds
WO2007019232A2 (en) * 2005-08-03 2007-02-15 Immunogen, Inc. Immunoconjugate formulations
MX2010012492A (es) * 2008-05-27 2010-12-21 Astrazeneca Ab Derivados de fenoxipiridinilamida y su uso en el tratamiento de estados de enfermedad mediados por fosfodiesterasa 4.
WO2022130091A1 (en) * 2020-12-18 2022-06-23 Philip Morris Products S.A. Inhaler article and capsule for use with the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU738037B2 (en) * 1997-04-04 2001-09-06 Pfizer Products Inc. Nicotinamide derivatives
GB0203193D0 (en) * 2002-02-11 2002-03-27 Pfizer Ltd Nicotinamide derivatives useful as pde4 inhibitors
MXPA04007737A (es) * 2002-02-11 2004-10-15 Pfizer Derivados de nicotinamida utiles como inhibidores de fosfodesterasas 4.

Also Published As

Publication number Publication date
GB0317509D0 (en) 2003-08-27
EP1651647A1 (en) 2006-05-03
MXPA06000988A (es) 2006-04-11
CA2533681A1 (en) 2005-02-03
WO2005010001A1 (en) 2005-02-03
JP2006528623A (ja) 2006-12-21

Similar Documents

Publication Publication Date Title
BR0307564A (pt) Derivados de nicotinamida úteis como inibidores de pde4
ECSP20027480A (es) Indolil alquil amino derivados sustituidos como nuevos inhibidores de la histona desacetilasa
BRPI0207172B8 (pt) pirido-pirimidinas 6-substituída, sua composição e seu uso, bem como seu intermediário
DK1625126T3 (da) Imidazo- og thiazolopyridiner som JAK3-kinaseinhibitorer
CU23218A3 (es) Derivados espirociclicos nuevos y su uso como inhibidores de fosfodiesterasa - 7
BRPI0510409A (pt) heterociclos bicìclicos contendo nitrogênio como inibidores da aromatase
BRPI0512588A (pt) derivados de uréia de pirimidina como inibidores de cinase
BRPI0410660A (pt) derivados de 2-amino-piridina como agonistas de adrenoreceptor ß2
TNSN05007A1 (en) Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof.
BR0307575A (pt) Derivados de sulfonila como inibidores de histona desacetilase
BR0207278A (pt) Derivados de ftalazinona-piperidina como inibidores de pde4
HN2003000062A (es) Derivados de nicotinamida utiles como inhibidores de pde4
CR6073A (es) Compuestos heterociclicos como inhibidores de enzimas de rotamasa
BRPI0414948A (pt) derivados de pirazolo-e-imidazo pirimidina
MXPA05004384A (es) Piperacinil y diacepanil benzamidas y benztioamidas.
HN2002000365A (es) Lactamas como antagonistas de taquiquininas
BRPI0412910A (pt) derivados de nicotinamida úteis como inibidores de pde4
BRPI0413094A (pt) derivados de quinolina e seu uso em terapia
BRPI0412862A (pt) derivados da nicotinamida úteis como inibidores de pde4
DK1448562T3 (da) Substituerede tetracycliske pyrroloquinolonderivater egnede som phosphodiesteraseinhibitorer
BRPI0412925A (pt) derivados de nicotinamida úteis como inibidores de pde4
PA8589801A1 (es) Aminoalcoxiindoles
BRPI0412933A (pt) derivados de nicotinamida úteis como inibidores de pde4
ATE509920T1 (de) Quadratsäurederivate als inhibitoren von histondeacetylase
CR7961A (es) Compuestos de aminoheteroarilo como inhibidores de las proteinquinasas

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]